Description
Product Description
Imanib 400 Tablet contains Imatinib Mesylate 400 mg, a targeted anticancer medicine belonging to the class of tyrosine kinase inhibitors. It is primarily used in the treatment of certain types of cancers such as Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and Gastrointestinal Stromal Tumors (GIST).
Imanib 400 works by blocking the action of abnormal proteins that signal cancer cells to multiply, thereby helping to stop or slow the spread of cancer. The tablet is taken orally and should be used only under the supervision of a qualified healthcare professional. It is important to take the medicine with food and water to minimize stomach irritation.
This medicine is prescription-only and must be stored in a cool, dry place below 30°C, protected from moisture and direct sunlight. Regular monitoring of blood counts and liver function is advised during treatment.
Product Specification
| Parameter | Specification |
|---|---|
| Brand Name | Imanib 400 |
| Generic Name | Imatinib Mesylate Tablets IP |
| Strength | 400 mg |
| Composition | Each film-coated tablet contains: Imatinib Mesylate IP equivalent to Imatinib 400 mg |
| Dosage Form | Film-Coated Tablet |
| Route of Administration | Oral |
| Indications / Uses | Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), Gastrointestinal Stromal Tumor (GIST), Hypereosinophilic Syndrome, Chronic Eosinophilic Leukemia |
| Mechanism of Action | Inhibits abnormal tyrosine kinases such as BCR-ABL and c-KIT, blocking cancer cell growth and promoting apoptosis |
| Packaging Type | Strip / Box |
| Pack Size | 10 Tablets per strip (or as per manufacturer) |
| Manufacturer / Marketer | [Insert Manufacturer / Marketing Company Name] |
| Shelf Life | 24 Months (Typical) |
| Storage Conditions | Store below 30°C, protect from moisture and direct sunlight |
| Prescription Type | Schedule H Drug – To be sold by retail on prescription of a registered medical practitioner only |
| Common Side Effects | Nausea, vomiting, muscle cramps, fatigue, edema, rash |
| Serious Side Effects | Liver dysfunction, fluid retention, unusual bleeding or bruising |
| Precautions | Use with caution in liver or kidney disease; avoid during pregnancy or breastfeeding unless advised by doctor |
| Drug Interactions | May interact with CYP3A4 inhibitors/inducers (e.g., ketoconazole, rifampicin), anticoagulants, and antiepileptics |
| Mode of Administration | Take orally with food and water as directed by a physician |
| Usage Instruction | Do not crush or chew the tablet; take at the same time each day for best results |
| Storage & Handling | Keep out of reach of children; dispose of safely as per biomedical waste guidelines |
Reviews
There are no reviews yet.